The US Food and Drug Administration (FDA) has authorized a monoclonal antibody drug against COVID-19, developed by GlaxoSmithKline and Vir, which claims to reduce hospitalisation and death among Coronavirus patients.
from Medindia Health News https://ift.tt/3uKkmQb
No comments:
Post a Comment